Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2019 Jul;154(1):83-88.
doi: 10.1016/j.ygyno.2019.04.012. Epub 2019 Apr 24.

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Gennaro Daniele  1 , Laura Arenare  2 , Giovanni Scambia  3 , Carmela Pisano  4 , Roberto Sorio  5 , Enrico Breda  6 , Sabino De Placido  7 , Antonella Savarese  8 , Gabriella Ferrandina  9 , Francesco Raspagliesi  10 , Pierluigi Benedetti Panici  11 , Antonella Ferro  12 , Anita Rimanti  13 , Gennaro Cormio  14 , Domenica Lorusso  15 , Sabrina Chiara Cecere  16 , Simona Scalone  17 , Valentina Angela Marsico  6 , Cinzia Cardalesi  18 , Francesco Cognetti  19 , Vanda Salutari  9 , Laura Attademo  20 , Lorenzo Guizzaro  21 , Clorinda Schettino  22 , Maria Carmela Piccirillo  23 , Francesco Perrone  24 , Ciro Gallo  25 , Sandro Pignata  26
Affiliations
Clinical Trial

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Gennaro Daniele et al. Gynecol Oncol. 2019 Jul.

Abstract

Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.

Keywords: Chemotherapy-induced neutropenia; Cytotoxic dosing methods; Meta-analysis; Ovarian cancer; Prognostic factors; Retrospective-prospective design.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources